Boston Historical Income Statement

0HOY Stock

90.94 1.30 1.45%

Historical analysis of Boston Scientific income statement accounts such as Total Revenue of 10.6 B, Gross Profit of 6.9 B or Other Operating Expenses of 9.8 B can show how well Boston Scientific Corp performed in making a profits. Evaluating Boston Scientific income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Boston Scientific's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Boston Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boston Scientific Corp is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Boston Income Statement Analysis

Boston Scientific Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Boston Scientific shareholders. The income statement also shows Boston investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Boston Scientific Income Statement Chart

At this time, Boston Scientific's Income Before Tax is comparatively stable compared to the past year. Net Income is likely to gain to about 1.7 B in 2024, whereas Total Revenue is likely to drop slightly above 10.6 B in 2024.

Total Revenue Gross Profit Research Development Total Operating Expenses Total Other Income Expense Net Tax Provision

Total Revenue

Total revenue comprises all receipts Boston Scientific Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Boston Scientific Corp minus its cost of goods sold. It is profit before Boston Scientific operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most accounts from Boston Scientific's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Total Revenue	11.9B	12.7B	14.2B	10.6B
Depreciation And Amortization	1.1B	1.1B	1.2B	1.0B

Total Revenue Depreciation And Amortization

Boston Scientific income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Interest Income	Selling General Administrative	Extraordinary Items
Depreciation And Amortization		0.95	0.86	0.31	0.67	0.62	0.95	0.78	0.96	-0.28	0.73	0.67	0.66	-0.13	0.52	-0.06	0.89	0.93
Total Revenue	0.95		0.97	0.41	0.85	0.82	0.99	0.92	0.93	-0.15	0.72	0.61	0.63	-0.1	0.49	0.04	0.96	0.87
Gross Profit	0.86	0.97		0.4	0.91	0.89	0.94	0.96	0.8	-0.1	0.71	0.59	0.63	-0.08	0.45	0.1	0.96	0.79
Other Operating Expenses	0.31	0.41	0.4		0.27	0.28	0.45	0.32	0.39	0.78	-0.3	-0.45	-0.33	0.04	0.37	0.02	0.53	0.43
Operating Income	0.67	0.85	0.91	0.27		0.99	0.8	0.98	0.65	-0.13	0.67	0.52	0.62	-0.14	0.29	0.25	0.8	0.57
Ebit	0.62	0.82	0.89	0.28	0.99		0.76	0.97	0.61	-0.09	0.63	0.48	0.57	-0.11	0.27	0.28	0.77	0.52
Research Development	0.95	0.99	0.94	0.45	0.8	0.76		0.88	0.94	-0.12	0.68	0.57	0.61	-0.14	0.47	0.0	0.94	0.9
Ebitda	0.78	0.92	0.96	0.32	0.98	0.97	0.88		0.76	-0.15	0.71	0.57	0.65	-0.13	0.37	0.2	0.87	0.68
Cost Of Revenue	0.96	0.93	0.8	0.39	0.65	0.61	0.94	0.76		-0.21	0.63	0.56	0.55	-0.14	0.5	-0.04	0.85	0.89
Total Operating Expenses	-0.28	-0.15	-0.1	0.78	-0.13	-0.09	-0.12	-0.15	-0.21		-0.76	-0.84	-0.71	0.08	0.03	0.08	0.0	-0.17
Income Before Tax	0.73	0.72	0.71	-0.3	0.67	0.63	0.68	0.71	0.63	-0.76		0.97	0.89	-0.05	0.22	-0.04	0.61	0.61
Total Other Income Expense Net	0.67	0.61	0.59	-0.45	0.52	0.48	0.57	0.57	0.56	-0.84	0.97		0.87	-0.03	0.16	-0.11	0.49	0.52
Net Income	0.66	0.63	0.63	-0.33	0.62	0.57	0.61	0.65	0.55	-0.71	0.89	0.87		-0.48	0.34	0.3	0.53	0.61
Income Tax Expense	-0.13	-0.1	-0.08	0.04	-0.14	-0.11	-0.14	-0.13	-0.14	0.08	-0.05	-0.03	-0.48		-0.34	-0.73	-0.07	-0.25
Tax Provision	0.52	0.49	0.45	0.37	0.29	0.27	0.47	0.37	0.5	0.03	0.22	0.16	0.34	-0.34		0.56	0.58	0.69
Interest Income	-0.06	0.04	0.1	0.02	0.25	0.28	0.0	0.2	-0.04	0.08	-0.04	-0.11	0.3	-0.73	0.56		0.06	0.08
Selling General Administrative	0.89	0.96	0.96	0.53	0.8	0.77	0.94	0.87	0.85	0.0	0.61	0.49	0.53	-0.07	0.58	0.06		0.89
Extraordinary Items	0.93	0.87	0.79	0.43	0.57	0.52	0.9	0.68	0.89	-0.17	0.61	0.52	0.61	-0.25	0.69	0.08	0.89

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.0B	1.1B	1.1B	1.1B	1.2B	1.0B
Total Revenue	10.7B	9.9B	11.9B	12.7B	14.2B	10.6B
Gross Profit	6.9B	5.6B	7.5B	7.7B	9.8B	6.9B
Other Operating Expenses	9.0B	9.3B	10.0B	10.9B	11.9B	9.8B
Operating Income	1.7B	601M	1.9B	1.8B	2.3B	1.5B
Ebit	1.7B	389M	1.8B	2.0B	2.4B	1.5B
Research Development	1.2B	1.1B	1.2B	1.3B	1.4B	1.2B
Ebitda	2.7B	1.5B	2.9B	3.2B	3.6B	2.5B
Cost Of Revenue	3.9B	4.3B	4.4B	5.0B	4.4B	3.7B
Total Operating Expenses	5.2B	5.0B	5.5B	5.9B	7.5B	4.4B
Income Before Tax	687M	(79M)	1.1B	1.1B	2.0B	2.1B
Total Other Income Expense Net	(1.0B)	(680M)	(846M)	(683M)	(359M)	(377.0M)
Net Income	4.7B	(82M)	1.0B	698M	1.6B	1.7B
Income Tax Expense	(4.0B)	2M	36M	443M	393M	412.7M
Tax Provision	(182M)	89M	2M	36M	41.4M	43.5M
Interest Income	72M	831M	7M	341M	306.9M	253.1M
Interest Expense	513M	468M	349M	464M	272M	324.7M
Selling General Administrative	3.6B	3.9B	3.7B	4.4B	5.0B	4.1B
Net Income Applicable To Common Shares	4.7B	(115M)	986M	642M	577.8M	1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC